Related Experiment Videos
[Ten questions on Brugada syndrome]
1Cardiologia, Ospedale P. Pederzoli, Peschiera del Garda (VR) - Cardiologia, Ospedale di Conegliano (TV) - Centro di Medicina di Conegliano (TV) e Mestre (VE) - Studio Micros, Modica (RG).
Insights
Brugada syndrome, a cause of sudden cardiac death, presents a challenge in identifying at-risk individuals from those with the Brugada ECG pattern. This paper aims to clarify risk assessment and future perspectives for managing Brugada syndrome.
Area of Science:
- Cardiology
- Electrophysiology
- Sudden Cardiac Death
Background:
- Brugada syndrome is linked to sudden cardiac death.
- A characteristic ECG pattern (type 1 Brugada ECG pattern) is associated with the syndrome.
- The prevalence of the Brugada ECG pattern in the general population necessitates risk stratification.
Purpose of the Study:
- To clarify diagnostic uncertainties surrounding Brugada syndrome.
- To identify individuals at high risk of sudden cardiac death within the general population.
- To provide definitive points and future perspectives for managing Brugada syndrome.
Main Methods:
- Review of current literature and clinical guidelines.
- Analysis of diagnostic criteria for Brugada syndrome.
- Discussion of risk stratification tools and their limitations.
Main Results:
- The Brugada ECG pattern is not uncommon, complicating risk assessment.
- Current diagnostic and risk stratification methods present challenges.
- Inconsistent clinical management strategies are observed among physicians.
Conclusions:
- Accurate risk stratification for Brugada syndrome remains a significant clinical challenge.
- Further research is needed to refine diagnostic criteria and management protocols.
- Clearer guidelines and improved understanding are essential for optimal patient care in Brugada syndrome.
Abstract:
Brugada syndrome is a possible cause of sudden cardiac death in subjects with characteristic ECG pattern (type 1 Brugada ECG pattern). Brugada ECG pattern is not infrequent in the general population and the challenge is to identify within a large population those patients who are really at risk. Unfortunately, this is a partially unresolved problem and this uncertainty determines an inhomogeneous behavior among doctors. Some of them overestimate the risk extensively indicating cardioverter-defibrillator implantation, others apply restrictive indications of guidelines, many are not able to decide without doubts.In this paper we will try to clarify some doubts, to give some certain points, and to draw some perspectives for the future.